Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: The NIH experience.
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Md.
Beatriz E
BE
Marciano
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Md.
Elisabeth S
ES
Allen
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Md.
Cathy
C
Conry-Cantilena
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Md.
Ervand
E
Kristosturyan
Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Md.
Harvey G
HG
Klein
Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Md.
Thomas A
TA
Fleisher
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Md.
Steven M
SM
Holland
Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, Md.
Harry L
HL
Malech
Immunology Service, Department of Laboratory Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Md; Primary Immunodeficiency Clinic, NIAID, National Institutes of Health, Bethesda, Md. Electronic address: srosenzweig@cc.nih.gov.
Sergio D
SD
Rosenzweig
D006098:Granulocytes / Q000637:transplantation*; D006105:Granulomatous Disease, Chronic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007239:Infections / Q000209:etiology* / Q000628:therapy*; D017708:Leukocyte Transfusion / Q000379:methods; D016896:Treatment Outcome